RhythmX AI, a generative AI-native company with a precision care platform for doctors, delivering hyper-personalized care to the right patient at the right time, announced that Ed Glynn, MD, MBA, FAAFP, has joined the leadership team as Chief Clinical Officer.
As a board-certified family physician and informaticist Dr. Glynn has been instrumental in enabling the standardization, modernization and optimization of HCA’s ambulatory EHR, which serves as the foundation of the clinical and office workflows across more than 1,600 locations and impacting the care of nearly 15 million patients annually.
“Dr. Glynn brings together real-world experience with clinical workflows at large health systems, practicing as a family physician and serving as an informaticist working across teams and among leaders at the largest scale,” said RhythmX AI CEO and founder Deepthi Bathina. “Experience at this point of intersection is a requirement for ongoing and compounding innovation, and the success of a hyper-personalized healthcare model. Dr. Glynn shares the priority we place on drawing from expert clinical experience and cutting edge AI to achieve a clear-eyed vision for what is required at the frontlines of medicine. He is committed to sustaining and expanding our partnership with the leading physicians championing hyper-personalized care today.”
“I am thrilled to join RhythmX AI as its first Chief Clinical Officer at this pivotal time in the healthcare industry,” said Dr. Glynn. “We are witnessing the explosion of artificial intelligence in daily life, the continued strain on our healthcare workforce, and the cry from patients for advanced, personalized care. In my new role, I will strive to gather the voices of our clinical experts, with their unique insights and expertise while leveraging the power of artificial intelligence. Our mission is to make delivering care easier, and more fulfilling for healthcare professionals while ensuring patients receive a more advanced, and hyper-personalized healthcare experience.”
Dr. Glynn’s role includes:
- Leading and delivering on innovation through a RhythmX AI platform that inspires high trust from clinicians globally
- Continuing to build and facilitate RhythmX AI’s distinguished external clinical expert panel and internal clinical staff. RhythmX AI’s expert panel will play a key role in end-to-end product development at the junction of AI and clinical experience, resulting in a platform bearing the distinguishing marks of leaders in their fields
- Orchestrating clinical and clinical informatics aspects of health AI products
- Advancing sustainable and efficient processes for on-going clinical validation of products and models
SOURCE: PRNewswire